SC
REFR icon

Sophrosyne Capital’s Research Frontiers REFR Stock Holding History

Sophrosyne Capital’s Portfolio REFR Stock Details REFR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-81,629
Closed -$418K – 40
2014
Q4 		$418K Buy
+81,629
New +$413K 0.64% 28

Other funds holding REFR

GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
Invicta Capital Management New York $125M AUM 14.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sophrosyne Capital's REFR Position: Q1 2015 in Review

Sophrosyne Capital sold out of Research Frontiers (REFR) in Q1 2015, closing a stake of 81,629 shares — an estimated $418K sold.

Sophrosyne Capital first reported a position in REFR in Q4 2014 and held it in 1 quarter. The position peaked at $418K in Q4 2014. 38 funds tracked by Wall St. Rank hold REFR as of Q1 2015.

  • Sophrosyne Capital reported no remaining Research Frontiers position as of Q1 2015 after selling out during the quarter.
  • Sophrosyne Capital sold 81,629 Research Frontiers shares in Q1 2015, an estimated $418K.
  • Sophrosyne Capital first reported a position in Research Frontiers in Q4 2014 and held it in 1 quarter.
  • Sophrosyne Capital's Research Frontiers position peaked at $418K in Q4 2014.
  • 38 funds tracked by Wall St. Rank held Research Frontiers as of Q1 2015.

Based on Sophrosyne Capital's 13F filing for Q1 2015, filed 20 Apr 2015.